Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.

Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA
Br J Ophthalmol. 2009 93 (5): 610-3

PMID: 19091853 · PMCID: PMC3490485 · DOI:10.1136/bjo.2008.150995

MeSH Terms (15)

Aged Aged, 80 and over Angiogenesis Inhibitors Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Complement Factor H Female Genotype Humans Macular Degeneration Male Ranibizumab Retrospective Studies Treatment Outcome Visual Acuity

Connections (1)

This publication is referenced by other Labnodes entities: